Aurinia Pharmaceuticals Inc, a nice little Canadian biotech from British Columbia who get some positive results from its AURORA Phase III trial of Voclosporin.

This news brings a nice premarket gap up by 99%.

The stock who was at $8.39 yesterday night start the day at $16.70 when the market open to get his high at $17.48 and finally close at $14.98.

Here is the detailed daily graph.

With a 41.5 Millions volume during the day, we saw some smaller gap up yesterday too when we see a 10 million volume exchanged and a price action who was near of his 52 weeks high with the press release of theirs presence to a conference. The news of this morning puts fire to bring the result than we see over here on the 30 days graph.

The lesson than we get over here for the one who get interested in the day trade, it’s than it could be a good idea to check if there is no news in the stock who are at their 52 weeks high..

Here is the complete press release of this morning: https://d1io3yog0oux5.cloudfront.net/_acad2005a5b897df655ee89635ab7b93/auriniapharma/news/2019-12-04_Aurinia_Announces_Positive_AURORA_Phase_3_Trial_164.pdf